(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -1.99%2.68B | -0.12%1.79B | 10.30%892.74M | -0.07%3.54B | 1.25%2.74B | 5.52%1.8B | 4.33%809.36M | 37.31%3.54B | 47.63%2.7B | 50.83%1.7B |
Operating income | -1.99%2.68B | -0.12%1.79B | 10.30%892.74M | -0.07%3.54B | 1.25%2.74B | 5.52%1.8B | 4.33%809.36M | 37.31%3.54B | 47.63%2.7B | 50.83%1.7B |
Operating expenses | -24.38%-1.21B | -32.11%-780.62M | -43.91%-387.03M | -9.71%-1.37B | -2.55%-969.89M | 0.83%-590.91M | 4.80%-268.94M | -18.07%-1.25B | -23.41%-945.76M | -17.91%-595.87M |
Gross profit | -16.45%1.48B | -15.92%1.01B | -6.42%505.72M | -5.42%2.16B | 0.55%1.77B | 8.93%1.21B | 9.55%540.41M | 50.73%2.29B | 65.05%1.76B | 77.51%1.11B |
Selling expenses | 0.91%-182.19M | 1.54%-120.36M | -2.31%-60.04M | -12.98%-251.74M | -15.83%-183.85M | -25.05%-122.23M | -14.07%-58.69M | -29.82%-222.82M | -33.19%-158.73M | -35.90%-97.75M |
Administrative expenses | -3.43%-115.13M | 4.17%-70.94M | -0.01%-35.87M | -13.68%-157.94M | -12.83%-111.3M | -23.66%-74.03M | -21.07%-35.87M | -23.99%-138.94M | -26.72%-98.65M | -26.91%-59.86M |
Research and development expenses | -6.07%-803.84M | -2.41%-540.3M | -11.83%-245.3M | -37.42%-1.01B | -35.35%-757.83M | -41.15%-527.6M | -30.06%-219.34M | -6.33%-735.42M | -17.46%-559.9M | -22.15%-373.78M |
Profit from asset sales | 383.87%2.45M | 150.68%925.63K | -99.85%616.57 | -7.00%1.24M | -67.28%505.59K | 8,117.86%369.25K | 30,297.78%403.38K | 156.10%1.33M | 864.81%1.55M | -102.60%-4.61K |
Revaluation surplus | 103.10%50K | 112.68%209.36K | -80.51%42.36K | -174.95%-1.4M | -194.94%-1.61M | -258.85%-1.65M | -64.46%217.3K | 96.86%1.87M | --1.7M | --1.04M |
-Changes in the fair value of other assets | 103.10%50K | 112.68%209.36K | -80.51%42.36K | -174.95%-1.4M | -194.94%-1.61M | -258.85%-1.65M | -64.46%217.3K | 96.86%1.87M | --1.7M | --1.04M |
Impairment and provision | 32.88%-69.85M | 72.56%-17.97M | 86.63%-4.33M | 8.99%-147.15M | -8.63%-104.07M | -38.20%-65.49M | -166.49%-32.36M | -144.28%-161.69M | -201.21%-95.8M | -172.33%-47.39M |
-Other impairment is provision | 32.88%-69.85M | 72.56%-17.97M | 86.63%-4.33M | 8.99%-147.15M | -8.63%-104.07M | -38.20%-65.49M | -166.49%-32.36M | -144.28%-161.69M | -201.21%-95.8M | -172.33%-47.39M |
Special items of operating profit | 113.93%142.04M | 112.33%102.72M | 83.27%26.23M | 69.50%178.39M | 27.45%66.4M | 92.95%48.38M | 0.66%14.31M | -0.88%105.24M | -24.37%52.1M | -38.85%25.07M |
Operating profit | -33.74%444M | -20.83%363.13M | -11.00%184.16M | -31.12%767.12M | -23.80%670.13M | -15.15%458.68M | -13.58%206.92M | 94.63%1.11B | 108.25%879.4M | 147.93%540.59M |
Financing cost | -478.91%-30.91M | -336.28%-18.58M | -756.49%-9.17M | -302.50%-15.7M | -156.10%-5.34M | 82.74%7.86M | 69.53%1.4M | 561.74%7.75M | 326.00%9.52M | 7,334.47%4.3M |
Special items of earning before tax | -202.77%-445.84K | -109,463,290.24%-448.8K | ---- | 290.44%433.8K | 290.73%433.8K | -100.00%0.41 | ---- | 25.48%111.1K | 6,307.85%111.02K | 1,174.91%21.22K |
Earning before tax | -37.97%412.64M | -26.24%344.11M | -16.00%174.99M | -32.96%751.85M | -25.17%665.23M | -14.38%466.54M | -13.30%208.31M | 95.57%1.12B | 109.43%889.03M | 149.98%544.91M |
Tax | -30.98%-1.7M | -73.98%-4.42M | -20.80%-16.65M | 29.53%-2.99M | 37.00%-1.3M | 24.22%-2.54M | -557.70%-13.78M | 69.94%-4.25M | 73.72%-2.06M | 46.67%-3.35M |
After-tax profit from continuing operations | -38.11%410.94M | -26.79%339.68M | -18.60%158.35M | -32.97%748.86M | -25.15%663.93M | -14.32%464M | -18.33%194.53M | 99.75%1.12B | 112.88%886.97M | 155.82%541.56M |
Special items of earning after tax | ---- | ---- | -9,300.00%-0.92 | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- |
Adjustment items of earning after tax | ---- | ---- | 9,300.00%0.92 | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- |
Earning after tax | -38.11%410.94M | -26.79%339.68M | -18.60%158.35M | -32.97%748.86M | -25.15%663.93M | -14.32%464M | -18.33%194.53M | 99.75%1.12B | 112.88%886.97M | 155.82%541.56M |
Minority profit | -218.24%-16.3M | -157.09%-8.41M | -146.27%-2.9M | -27.35%29.36M | -50.40%13.79M | 33.57%14.73M | 19.36%6.27M | -9.89%40.42M | -2.22%27.8M | -36.45%11.03M |
Profit attributable to shareholders | -34.29%427.24M | -22.52%348.09M | -14.35%161.25M | -33.18%719.49M | -24.33%650.14M | -15.32%449.27M | -19.18%188.26M | 109.31%1.08B | 121.31%859.17M | 172.99%530.53M |
Basic earnings per share | -35.00%0.52 | -23.64%0.42 | -13.04%0.2 | -33.33%0.88 | -23.81%0.8 | -15.38%0.55 | -20.69%0.23 | 91.30%1.32 | 94.44%1.05 | 132.14%0.65 |
Diluted earnings per share | -34.18%0.52 | -23.64%0.42 | -13.04%0.2 | -33.59%0.87 | -24.76%0.79 | -15.38%0.55 | -17.86%0.23 | 89.86%1.31 | 94.44%1.05 | 132.14%0.65 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data